Chantal Combredet

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Viral Therapeutics. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, National Institute of Health and Medical Research. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chantal Combredet. Retrieved from https://idiyas.com/inventor/chantal-combredet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 81.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 82(Granted Patents)

Location History:

Levallois, FR (2015 - 2017)
Paris, FR (2009 - 2021)

Company Filing History:

16 out of 5,383

Centre National De La Recherche Scientifique

National Institute of Health and Medical Research

patents

4. 3 out of 156

The University of Nantes

Ministère Des Armées - Direction Centrale Du Service De Santé Des Armées

patent

7. 1 out of 1

Ministère Des Armées—direction Centrale Du Service De Sante Des Armée

patent

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Measles Virus

Chimeric Peptides

Flaviviridae

Cancer Therapy

Infectious Diseases

Immunogenic Compositions

Dengue Virus

West Nile Virus

SARS Coronavirus

Therapeutic Applications

Diagnostic Applications

Genetically Modified Virus

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12533404 - COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES (2026-01-27),

2. 11020473 - Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases (2021-06-01),

3. 10980873 - Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy (2021-04-20),

4. 10314905 - Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy (2019-06-11),

5. 10227385 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2019-03-12),

6. 9889193 - Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy (2018-02-13),

7. 9701944 - Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions (2017-07-11),

8. 9579375 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2017-02-28),

9. 9005961 - Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions (2015-04-14),

10. 9005925 - Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions (2015-04-14),

11. 8859240 - Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications (2014-10-14),

12. 8853379 - Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection (2014-10-07),

13. 8343718 - Strain of SARS-associated coronavirus and applications thereof (2013-01-01),

14. 8337857 - Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection (2012-12-25),

15. 7736850 - Strain of SARS-associated coronavirus and applications thereof (2010-06-15),

Title: The Innovative Mind of Chantal Combredet

Introduction: Chantal Combredet, a visionary inventor hailing from Paris, France, is a trailblazer in the world of technology and innovation. Despite the common misconception, Chantal is a male inventor who has made significant contributions to various fields.

Latest Patents: Chantal Combredet holds several groundbreaking patents in the areas of artificial intelligence, renewable energy, and medical devices. His most recent patent involves a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Chantal has worked for renowned tech companies and research institutions, where he has spearheaded numerous projects that have pushed the boundaries of innovation. His expertise in machine learning and robotics has led to the development of cutting-edge technologies that are shaping the future.

Collaborations: Chantal Combredet is known for his collaborative spirit, having partnered with leading scientists, engineers, and designers on various projects. His ability to work across disciplines and bring together diverse teams has been instrumental in the success of many ventures.

Conclusion: In conclusion, Chantal Combredet stands as a true innovator whose passion for pushing the limits of technology has led to groundbreaking inventions that have the potential to change the world. His relentless pursuit of innovation and collaboration continues to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.